Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer

Immune checkpoints are intensively investigated as targets in cancer therapy. T-cell immunoreceptor with immunoglobulin (Ig) and ITIM domains (TIGIT) and its ligand poliovirus receptor (PVR) are recently emerging as novel promising targets in immunotherapy. Here, we show that high expression of PVR...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Stamm, Hauke, Oliveira-Ferrer, Leticia, Grossjohann, Eva-Maria, Muschhammer, Jana, Thaden, Vanessa, Brauneck, Franziska, Kischel, Roman, Müller, Volkmar, Bokemeyer, Carsten, Fiedler, Walter, Wellbrock, Jasmin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6844319/
https://ncbi.nlm.nih.gov/pubmed/31741778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1674605
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller